Statistics for Candel Therapeutics, (id:6970 CADL)

Valuation metrics

Market cap

163.68M

Enterprise value

135.07M

Trailing P/E (ttm)

-3.85

Forward P/E

-5.54

PEG ratio

-5.54

Price/Sales (ttm)

Price/Book (mrq)

11.51

Enterprise Value/Revenue

Enterprise Value/EBITDA

-3.90

Overview

Shares outstanding

32.48M

Float

21.68M

Shares short

1.78M

% Held by insiders

0.30%

% Held by institutions

0.23%

Average volume (10 days)

606.32K

Average volume (90 days)

Price summary

52-Week low

0.77

52-Week high

14.30

52-Week change

80.56%

Beta

-0.87

50-Day moving average

5.86

200-Day moving average

5.66

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

0.00%

Operational effectiveness

Return on assets

-52.31%

Return on equity

-480.68%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-34,658,000.00

Net income to common (ttm)

-49,988,000.00

Diluted EPS (ttm)

-1.73

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

21.45M

Total cash per share (mrq)

0.67

Total debt (mrq)

18.56M

Total Debt/Equity (mrq)

-1.22

Current ratio (mrq)

162.40%

Book value per share (mrq)

0.44

Cash flow

Cash flow statement

-30,866,000.00

Levered free cash flow (LFCF)

-18,402,376.00